Bank of Montreal
RPRX

Bank of Montreal’s Repros Therapeutics Inc. RPRX Stock Holding History

Bank of Montreal’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-8,800
Closed -$87K – 4415
2014
Q3 		$87K Hold
8,800
– – ﹤0.01% 2895
2014
Q2 		$152K Sell
8,800
-42,400
-83% -$691K ﹤0.01% 2628
2014
Q1 		$908K Buy
51,200
+41,200
+412% +$797K ﹤0.01% 1715
2013
Q4 		$183K Buy
10,000
+4,900
+96% +$92.5K ﹤0.01% 2277
2013
Q3 		$137K Buy
+5,100
New +$109K ﹤0.01% 2398

Bank of Montreal's RPRX Position: Q1 2018 in Review

Bank of Montreal sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 1,000 shares — an estimated $1K sold.

Bank of Montreal first reported a position in RPRX in Q2 2013 and held it in 19 quarters. The position peaked at $244K in Q1 2014. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.

  • Bank of Montreal reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
  • Bank of Montreal sold 1,000 Repros Therapeutics Inc. shares in Q1 2018, an estimated $1K.
  • Bank of Montreal first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 19 quarters.
  • Bank of Montreal's Repros Therapeutics Inc. position peaked at $244K in Q1 2014.
  • 1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.

Based on Bank of Montreal's 13F filing for Q1 2018, filed 13 Apr 2018.